Article Sidebar

PDF
Date Published: 19/08/2024
Abstract Views: 121
Views PDF: 63
DOI: https://doi.org/10.51298/vmj.v541i2.10771
Issue
Vol. 541 No. 2 (2024)
Section
Các bài báo
How to Cite
Trần, M. H., & Đinh, T. H. T. (2024). IMMUNOLOGICAL CHARACTERISTICS OF BREAST CARCINOMA IN WOMAM TREATED AT THAIBINH GENERAL HOSPITAL. Vietnam Medical Journal, 541(2). https://doi.org/10.51298/vmj.v541i2.10771

IMMUNOLOGICAL CHARACTERISTICS OF BREAST CARCINOMA IN WOMAM TREATED AT THAIBINH GENERAL HOSPITAL

Mạnh Hà Trần, Thị Huyền Trang Đinh

Main Article Content

Abstract

Objective: To evaluate the expression of immunohistochemical markers of breast carcinoma in women treated at Thai Binh General Hospital. Methods: cross-sectional descriptive study. The study was conducted on 52 breast carcinoma patients examined and treated at Thai Binh General Hospital. Results: ER, PR: ER (63.5%) is more often expressed than PR (44.3%), co-expression is common in tubular type A, co-negative is highest in type HER2. HER2: HER2(-/1+) in 61.6%, common in tubular type A, mainly expressed in HER2 molecular type and HER2(+) lumen type B. Ki67: usually low expression in tubular type A (36.5%), in tubular type B with HER2(+) and high expression (30.8%) in HER2 type and basal type.

Article Details

Keywords

breast carcinoma; immunohistochemistry

References

1. Ferlay J, Soerjomataram I, Jemal A, et al (2020). GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021 May; 71(3): 209-249.
2. Spitale A, Mazzla P, Soldini D, et al (2009). Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South ò Switzerland. Annals of Oncology, 20, 628-35.
3. Tạ Văn Tờ (2004). Nghiên cứu hình thái học, hóa mô miễn dịch và giá trị tiên lượng của chúng trong ung thư biểu mô tuyến vú, Luận án Tiến sĩ Y học, Trường Đại học Y Hà Nội.
4. Kroman N, Wohlfart J, Henning T, et al (2003). Influence of tumor location on breast cancer prognosi. Int. J. Cancer, 105, 542-45.
5. Đoàn Thị Phương Thảo (2012). Nghiên cứu gen HER2 và phân nhóm phân tử ung thư vú, Luận án Tiến sĩ Y học, Trường Đại học Y-Dược, thành phố Hồ Chí Minh.
6. Nguyễn Văn Chủ (2016). Nghiên cứu áp dụng phân loại phân tử ung thư biểu mô tuyến vú bằng phương pháp hóa mô miễn dịch. Luận án tiến sĩ y học.
7. Mohsin S.K, Weiss H, Havighurst, et al (2004). Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study.
8. Brien O K.M, Cole S.R and Tse C.K, et al (2010). Intrinsic Breast Tumor Subtypes, Race, and Long-Term Survival in the Carolin a Breast Cancer Study. Clin Cancer Res, 16(24), 6100-10
9. Bhargava R, Esposito N.N and Dabbs D.J (2010). Immunohistology of the Breast. Diagnostic Immunohistochemistry: Theranostic and genomic applications, Saunders, USA, 763-819.